Mastectomy | Breast-conserving surgery | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Transfused patients, N | All patients, N | Risk (%) | Crude OR (95% CI) | Adjusted OR* (95% CI) | Transfused patients, N | All patients, N | Risk (%) | Crude OR (95% CI) | Adjusted OR* (95% CI) | ||
Aspirin | |||||||||||
Non-users | 178 | 6406 | 2.8 | 1.0 (ref) | 1.0 | 54 | 14,496 | 0.4 | 1.0 | 1.0 | p = 0.87 |
Users | 37 | 529 | 7.0 | 2.6 (1.8–3.8) | 1.9 (1.3–2.9) | 10 | 807 | 1.2 | 3.4 (1.7– 6.6) | 1.8 (0.9–3.8) | |
NSAIDs | |||||||||||
Non-users | 187 | 6324 | 3.0 | 1.0 | 1.0 | 60 | 14,140 | 0.4 | 1.0 | 1.0 | p = 0.23 |
Users | 28 | 611 | 4.6 | 1.6 (1.1–2.4) | 1.4 (1.0–2.2) | 4 | 1163 | 0.3 | 0.8 (0.3–2.2) | 0.7 (0.3–2.0) | |
SSRIs | |||||||||||
Non-users | 198 | 6551 | 3.0 | 1.0 | 1.0 | 62 | 14,607 | 0.4 | 1.0 | 1.0 | p = 0.23 |
Users | 17 | 384 | 4.4 | 1.5 (0.9–2.5) | 1.3 (0.8–2.2) | 2 | 696 | 0.3 | 0.7 (0.2– 2.8) | 0.5 (0.1–2.2) | |
Statins | |||||||||||
Non-users | 189 | 6300 | 3.0 | 1.0 | 1.0 | 59 | 13,909 | 0.4 | 1.0 | 1.0 | p = 0.29 |
Users | 26 | 635 | 4.1 | 1.4 (0.9–2.1) | 1.1 (0.7–1.7) | 5 | 1394 | 0.4 | 0.8 (0.3–2.1) | 0.6 (0.2–1.6) |